News
2022.09.15
fcuro is selected as Acceleration program “SCAP” assisting startups in expanding business overseas intensively.
2022.08.02
fcuro is selected as a participant company of the supporting program for international cooperation in Aichi-Nagoya Acceleration Project for International Cooperation -BEYOND-.
2022.07.04
Our activity is featured on Link-J’s webpage.
2022.06.30
Our project is selected for “Project Planning for the Demonstration and Introduction of Key Technologies for the Realization of the New Normal” by Mitsubishi Research Institute, Inc.
2022.06.11
CTO Shusuke Inoue gives a presentation at The 8th Annual Congress of the Japan Society of Clinical Safety.
2022.04.22
Our project is selected for “FY2022 AMED Medical Innovation Promotion Project (Development and Commercialization Project) , Venture Development”.
2021.12.23
fcuro wins the award for best pitch at “BRAVE 2021 DEMO DAY”, a pitch competition for next-generation deep tech entrepreneurs
2021.11.21
CEO Naoki Okada gives a presentation at a symposium for the study of AI in acute medicine in “The 49th Annual Meeting of the Japanese Association for Acute Medicine”.
2021.10.21
fcuro exhibits projects at Bio Japan 2021.
2021.06.09
fcuro signs a joint research agreement with Osaka General Medical Center.
2021.05.27
Our project is selected for “Project Planning for the Demonstration and Introduction of Key Technologies for the Realization of the post-pandemic era” by Mitsubishi Research
2021.03.26
fcuro signs a joint research agreement with Shizuoka Saiseikai General Hospital.
2021.02.14
CEO Naoki Okada gives a lecture at The 48th Annual Meeting of the Japanese Society of Intensive Care Medicine.
2021.01.01
Our joint research project with Osaka General Medical Center is selected for a recommended AI-research by the Japanese Association for Acute Medicine.
2020.12.04
Our project is selected for “COVID-19 AI & Simulation Project” by Cabinet Secretariat.
2020.10.01
Our project is selected for “FY2020 NEDO Entrepreneurs Program”.
2020.07.06
CEO Naoki Okada and CTO Inoue are selected for the “FY2020 Mitou Advanced Project” by IPA (Information-technology Promotion Agency).
2020.02.21
CEO Naoki Okada is selected for “The first Mitou AI Frontier Project”, and is awarded AI frontier pathfinder (acute medicine).